Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial evaluating a combination of biological therapy and monoclonal antibody therapy in patients with relapsed or refractory Non-Hod…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial evaluating epratuzumab for Non-Hodgkin lymphoma; current status/details are not provided.
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides [Phase 2]
This entry provides an update on a Phase 2 trial of combination chemotherapy for advanced or recurrent mycosis fungoides. Mycosis fungoides …
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
This clinical trial update describes a Phase 2 study of a monoclonal antibody therapy for patients with relapsed or refractory Non-Hodgkin l…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial of a geldanamycin analogue in patients with advanced solid tumors or Non-Hodgkin lymphoma has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Radiolabeled Monoclonal Antibody in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 clinical trial of a radiolabeled monoclonal antibody for relapsed or refractory Non-Hodgkin lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells [Phase 3]
Phase 3 trial evaluating whether prophylactic moxifloxacin after high-dose chemotherapy with peripheral stem cell transplantation reduces ba…
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Rapid Rituximab Infusion at 90-minute Among Non-Hodgkin Lymphoma [NA]
A clinical trial update reports on a rapid 90-minute rituximab infusion protocol for non-Hodgkin lymphoma; trial status is completed.
-
CLINICAL_TRIALS trial_result · 2013-12-09Clinical Trial Update: Expanded Access Study Of BEXXAR® For Low Grade And Transformed Low-Grade Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 expanded-access study of BEXXAR for low-grade and transformed low-grade non-Hodgkin lymphoma completed with results posted.
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Efficacy and Safety Study of Oral Fludarabine Phosphate in Combination With Mitoxantrone as First Line Treatment in Follicular NHL [Phase 2]
Phase 2 study evaluating the efficacy and safety of combining oral fludarabine phosphate with mitoxantrone as first-line therapy for follicu…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 clinical trial evaluating chemotherapy followed by Genitope idiotype vaccine therapy plus sargramostim in stage III or IV Non-Hodgki…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial is evaluating the combination of chemotherapy with Rituximab in patients with intermediate-grade or high-grade Non-…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: A Clinico-Pathological Study to Investigate the Possible Infective Causes of Non-Hodgkin Lymphoma of the Ocular Adnexae [Phase 2]
A completed Phase 2 clinico-pathological study sponsored by IELSG investigates possible infectious causes of Non-Hodgkin lymphoma of the ocu…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating myeloablative allogeneic stem cell transplantation with a naive T-cell depleted peripheral blood graft…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match [Phase 2]
Phase 2 trial evaluating pooled unrelated donor umbilical cord blood transplant for hematologic malignancies requiring allogeneic stem cell …
-
CLINICAL_TRIALS trial_result · 2013-11-18Clinical Trial Update: Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation [Phase 1, Phase 2]
This clinical trial update covers ASC-101 in patients with hematologic malignancies undergoing dual-cord umbilical cord blood transplantatio…
-
CLINICAL_TRIALS trial_result · 2013-11-18Clinical Trial Update: Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma [NA]
This clinical trial studied radioimmunotherapy with 90Y Zevalin for orbital lymphoma and has completed, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial of liposomal vincristine in patients with refractory or relapsed Non-Hodgkin lymphoma has completed, with results reported f…
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function [Phase 1]
Phase 1 pharmacokinetics and safety study of azacitidine in cancer patients with and without impaired renal function has completed. Results …
-
CLINICAL_TRIALS trial_result · 2013-10-14Clinical Trial Update: Evaluation of Bay 59-8862 in Patients With Aggressive, Refractory Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial evaluating Bay 59-8862 for aggressive, refractory Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-27Clinical Trial Update: VELCADE,Rituximab,Cyclophosphamide and Decadron [Phase 2]
Phase 2 trial update for Velcade in combination with Rituximab, Cyclophosphamide, and Decadron in B-cell non-Hodgkin lymphoma, with terminat…
-
CLINICAL_TRIALS trial_result · 2013-09-25Clinical Trial Update: Use of Topotecan in Patients With Refractory Acute Leukemia [Phase 2]
Trial update on a Phase 2 study of topotecan in patients with refractory leukemia and non-Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma [Phase 3]
A Phase 3 trial evaluating chemotherapy plus peripheral stem cell transplantation with or without rituximab for relapsed Non-Hodgkin lymphom…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 clinical trial evaluating chemotherapy and radiation therapy plus bone marrow transplantation for aggressive non-Hodgkin lymphoma; c…
-
CLINICAL_TRIALS trial_result · 2013-09-16Clinical Trial Update: Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
Clinical trial update reports safety and efficacy results for IDEC-114 in combination with Rituxan in non-Hodgkin lymphoma, with the Phase 1…